For nearly a decade, Indian EdTech was synonymous with speed—rapid user acquisition, aggressive fundraising, and the race to become an all-in-one “education super app.” The pandemic amplified this momentum, compressing years of adoption into months. But as classrooms reopened and capital markets tightened, the sector entered a period of correction. What once worked, blanket marketing, […]
Read More
The EdTech market has evolved rapidly over the past decade, accelerated by pandemic-era demand and the proliferation of online learning. However, as the sector matures, founders face the stark reality that great content alone does not guarantee adoption or revenue. In India, K-12 platforms, test-prep programs, and upskilling courses must contend with skeptical parents, limited […]
Read More
EdTech founders frequently make a catastrophic assumption: that education is a “viral” consumer product. They build AI-powered adaptive platforms, hire celebrity educators, and expect the product to sell itself. Instead, they find themselves trapped in a cycle of stagnant conversion (2–5%) and spiraling CAC (₹2,000–4,000). The problem is rarely the product; it is the misunderstanding […]
Read More
EdTech founders make a binary assumption: should we sell B2C to parents or B2B to schools? This framing is dangerously incomplete. It ignores B2B2C models where schools distribute, but parents pay, enterprise B2B serving corporate upskilling, distinct from K-12 institutional sales, and the reality that most successful EdTech companies operate hybrid models rather than pure […]
Read More
EdTech founders make a fatal assumption: education sells itself if the product is good. They build AI-powered adaptive learning platforms, hire celebrity teachers, and create comprehensive content libraries. When GTM launches, they discover parents do not buy immediately despite product quality. Conversion rates hover at 2-5%. CAC spirals to ₹2,000-4,000. Retention collapses after 3 months […]
Read More
HealthTech founders fear pivots. They interpret business model changes as admissions of failure, signs that they picked the wrong market or built the wrong product. This mindset is catastrophic in healthcare, where regulatory shifts, technological breakthroughs, and market dynamics evolve faster than product development cycles. Strategic pivots are not failures. They are operational necessities in […]
Read More